The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells.
about
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617FImetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis.p53 at the crossroads of MPN treatment.JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis.Myeloproliferative neoplasm stem cells.Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer.Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches.Developmental Therapeutics in Myeloproliferative Neoplasms.SOHO State-of-the-Art Update and Next Questions: MPN.Long-acting interferon for myeloproliferative neoplasms - an update.
P2860
Q26795666-A259D380-88A3-4863-ADE0-3313D664D1CDQ33439918-9ED83DB5-03C7-4916-A5ED-4848691119C9Q33987032-50844E63-A851-4C7D-B782-71DF511A8DA8Q34471806-3A115CB4-14AE-4F77-A17F-91FACC5521A0Q39118859-3CE1DA59-B45B-4FC1-9BF1-E0C3AC955813Q42378380-D580C0FC-76E6-49E6-8874-7D7721C195FBQ47102210-61C2BB39-8D25-46DD-9674-347A5F9465B1Q48008083-A502FBFF-E13E-45DD-ABC6-DF9BC1EDF4E8Q49580473-6C1F5CA7-B6BD-40CA-BF80-612E0CBF302CQ50489851-D1DDAA79-2012-4708-AEA9-889F81815990
P2860
The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The orally bioavailable MDM2 a ...... ive progenitor and stem cells.
@ast
The orally bioavailable MDM2 a ...... ive progenitor and stem cells.
@en
type
label
The orally bioavailable MDM2 a ...... ive progenitor and stem cells.
@ast
The orally bioavailable MDM2 a ...... ive progenitor and stem cells.
@en
prefLabel
The orally bioavailable MDM2 a ...... ive progenitor and stem cells.
@ast
The orally bioavailable MDM2 a ...... ive progenitor and stem cells.
@en
P2093
P2860
P1433
P1476
The orally bioavailable MDM2 a ...... ive progenitor and stem cells.
@en
P2093
P2860
P304
P356
10.1182/BLOOD-2013-11-536854
P407
P577
2014-05-28T00:00:00Z